AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

755.666

+7.7451.04%

Number of Gainers:17

Number of Losers:12

Number of Flat:16

PE:- -

High:756.356

Open:753.505

Low:749.555

Close:747.921

Volume:43.52M

Turnover:201.05M

Market Cap:114.75B

Float Cap:111.15B

Loading ...

Crypto-Friendly Bank Nubank Announces Application for US Bank Charter

BRIEF-Orthocell Ltd Says Revenue Of A$3.0 Mln Achieved For Quarter Ended 30 Sept

BUZZ-Jefferies trims CSL's PT but stays upbeat on growth; shares rise

Orthocell's September Quarter Revenue Rises Sequentially to Record High

MT Newswires Live

Race Oncology Discovers Anticancer Activity of Bisantrene

MT Newswires Live

Orthocell Ltd - Revenue of a$3.0 Mln Achieved for Quarter Ended 30 Sept

THOMSON REUTERS

Paradigm Biopharmaceuticals Limited's (ASX:PAR) Shift From Loss To Profit

Simply Wall St.

NewMarket Completes Acquisition of Calca Solutions

MT Newswires Live

ASX Growth Stocks With High Insider Ownership To Watch

Simply Wall St.

BUZZ-Australia's Anatara Lifesciences falls on discounted placement

BRIEF-Bioxyne Ltd's Unit Well Positioned To Capitalise On Easing Regulations On U.S. Cannabis Classification

BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement

Bioxyne Ltd - Unit Well Positioned to Capitalise on Easing Regulations on U.S. Cannabis Classification

THOMSON REUTERS

Stripe is planning to apply for an OCC federal trust charter to comply with U.S. stablecoin regulatory requirements

Anatara Lifesciences Ltd - Receives Firm Commitments for a$1.2M Placement at a$0.012/Share

THOMSON REUTERS

Timing of CSL's Change of CFO Queried by Bull -- Market Talk

BRIEF-Clinuvel Pharmaceuticals Announces Philippe Wolgen Resumes Duties As CEO

Clinuvel Pharmaceuticals Ltd - Announces DR Philippe Wolgen Resumes Duties as CEO

THOMSON REUTERS

Immuron Limited Announces Auditor Consent from Grant Thornton in Latest SEC Filing

Radiopharm Theranostics Ltd: Co Partners With Starpharma on Research and Option Agreement to Develop Novel Radiotherapy Asset

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":755.666,"timestamp":1760072399855,"preClose":747.92145,"halted":0,"volume":43515793,"delay":0,"changeRate":0.010355,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":7.744568,"latestTime":"10-10 16:00:00 AEDT","open":753.5048,"high":756.3559,"low":749.5553,"amount":201050700,"amplitude":0.009093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1760310000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1760050800000,1760072400000]],"turnoverRate":0.001558,"increases":13,"decrements":13,"flats":17,"marketCap":114748171758,"floatMarketCap":111152797876.5625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":756.3559,"amplitude":0.009093,"preClose":747.92145,"low":749.5553,"latestPrice":755.666,"volume":43515793,"delay":0,"open":753.5048,"prevYearClose":936.801,"prevWeekClose":749.725,"prevMonthClose":712.826,"prevQuarterClose":712.826,"fiveDayClose":749.725,"twentyDayClose":740.889,"sixtyDayClose":876.9,"secType":"PLATE","market":"AU","turnoverRate":0.001558,"marketCap":114748171758,"floatMarketCap":111152797876.5625,"timestamp":1760072399855,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":17,"down":12,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572560445","title":"Crypto-Friendly Bank Nubank Announces Application for US Bank Charter","url":"https://stock-news.laohu8.com/highlight/detail?id=2572560445","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572560445?lang=en_us&edition=fundamental","pubTime":"2025-10-02 10:31","pubTimestamp":1759372260,"startTime":"0","endTime":"0","summary":"BlockBeats News, October 2nd, according to businesswire, crypto-friendly bank Nubank announced that it has applied to the Office of the Comptroller of the Currency  for a banking license to explore banking operations in the United States. If approved, this would allow the bank to offer deposit accounts, credit cards, loans, and digital asset custody services in the U.S. market.It is reported that Nubank launched a cryptocurrency transfer feature last year, allowing users to send and receive crypto assets through their wallets, supporting Bitcoin, Ethereum, and the Solana network.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/314794","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/314794","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BTC.USD.CC","OCC.AU","BK4534","LU0130103400.USD","LU0070302665.USD","ETHU","LU0980610538.SGD","LU0648000940.SGD","LU0289960550.SGD","LU0208291251.USD","LU0211331839.USD","BK4020","LU0130518102.USD","LU0477156797.USD","LU1201861249.SGD","LU0320765489.SGD","ETH.USD.CC","OCC","BK4585","BK7508","BK4100","BTC.USD.HKCC","CHTR","LU1201861165.SGD","LU0130102774.USD","LU0477156953.USD","BK4588","BK7067","LU0130517989.USD","SOL.USD.HKCC","LU0175139822.USD","BK4559","ETH.USD.HKCC","LU0648001328.SGD"],"gpt_icon":0},{"id":"2572562802","title":"BRIEF-Orthocell Ltd Says Revenue Of A$3.0 Mln Achieved For Quarter Ended 30 Sept","url":"https://stock-news.laohu8.com/highlight/detail?id=2572562802","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572562802?lang=en_us&edition=fundamental","pubTime":"2025-10-02 09:26","pubTimestamp":1759368381,"startTime":"0","endTime":"0","summary":"BRIEF-Orthocell Ltd Says Revenue Of A$3.0 Mln Achieved For Quarter Ended 30 SeptOct 2 (Reuters) - Orthocell Ltd OCC.AX:REVENUE OF A$3.0 MILLION ACHIEVED FOR QUARTER ENDED 30 SEPTFurther company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VI18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2572649995","title":"BUZZ-Jefferies trims CSL's PT but stays upbeat on growth; shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2572649995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572649995?lang=en_us&edition=fundamental","pubTime":"2025-10-02 09:09","pubTimestamp":1759367343,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies trims CSL's PT but stays upbeat on growth; shares rise** Jefferies lowers CSL's CSL.AX PT to A$275 from A$288, but remains constructive on long-term growth, highlighting continued plasm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nL6N3VJ030:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","CSL.AU","BK7508","BK7501"],"gpt_icon":0},{"id":"2572219569","title":"Orthocell's September Quarter Revenue Rises Sequentially to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=2572219569","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572219569?lang=en_us&edition=fundamental","pubTime":"2025-10-02 08:08","pubTimestamp":1759363727,"startTime":"0","endTime":"0","summary":"Orthocell  reported a record quarterly revenue of AU$3 million for the September quarter, up 9.1% quarter over quarter, according to a Thursday Australian bourse filing.The result represented the sixth consecutive quarter of record revenue, and it was primarily driven by increased market penetration in existing markets, particularly Australia and Singapore.Growth in the sales of the firm's Remplir nerve repair product is expected to be further supplemented by market entry in Canada, the filing said. The expected adoption of Remplir by surgeons in the US represents a potential for an increase in revenue growth.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","BK7067","BK7508","OCC.AU","XJO.AU","XAO.AU"],"gpt_icon":0},{"id":"2572356911","title":"Race Oncology Discovers Anticancer Activity of Bisantrene","url":"https://stock-news.laohu8.com/highlight/detail?id=2572356911","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572356911?lang=en_us&edition=fundamental","pubTime":"2025-10-02 08:01","pubTimestamp":1759363274,"startTime":"0","endTime":"0","summary":"Race Oncology  said scientific activities carried out by the firm and its collaborators identified the anticancer activity of (E,E)-bisantrene drug candidate, according to a Thursday Australian bourse filing.Bisantrene's activity predominantly results from binding and stabilizing of regulatory DNA and RNA structures called G-quadruplexes found throughout the human genome, sequences of which form three-dimensional structures that regulate the expression and translation of many genes involved in causing cancer, including the master cancer growth regulator, MYC.Studies conducted by Race found that potent downregulation of the MYC gene occurs shortly after treatment with bisantrene, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","RAC.AU","BK7508"],"gpt_icon":0},{"id":"2572565271","title":"Orthocell Ltd - Revenue of a$3.0 Mln Achieved for Quarter Ended 30 Sept","url":"https://stock-news.laohu8.com/highlight/detail?id=2572565271","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572565271?lang=en_us&edition=fundamental","pubTime":"2025-10-02 06:55","pubTimestamp":1759359345,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VI18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","OCC.AU"],"gpt_icon":0},{"id":"2572593472","title":"Paradigm Biopharmaceuticals Limited's (ASX:PAR) Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2572593472","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572593472?lang=en_us&edition=fundamental","pubTime":"2025-10-02 06:35","pubTimestamp":1759358107,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals Limited ( ASX:PAR ) is possibly approaching a major achievement in its business, so we...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-par/paradigm-biopharmaceuticals-shares/news/paradigm-biopharmaceuticals-limiteds-asxpar-shift-from-loss","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-par/paradigm-biopharmaceuticals-shares/news/paradigm-biopharmaceuticals-limiteds-asxpar-shift-from-loss","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","PAR","BK7508","BK4157","PAR.AU"],"gpt_icon":0},{"id":"2572687265","title":"NewMarket Completes Acquisition of Calca Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2572687265","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572687265?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:30","pubTimestamp":1759354258,"startTime":"0","endTime":"0","summary":"NewMarket  completed the acquisition of Mars TopCo, the parent company of Calca Solutions, which manufactures propellants for advanced aerospace and defense applications.The terms of the transaction weren't disclosed. Lake Charles, Louisiana-based Calca had been a portfolio company of AE Industrial Partners.The acquisition is projected to boost net income in 2026, NewMarket said Wednesday in a statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NEU.AU","BK4109","BK7096","NEU","BK7508"],"gpt_icon":0},{"id":"2572566669","title":"ASX Growth Stocks With High Insider Ownership To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2572566669","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572566669?lang=en_us&edition=fundamental","pubTime":"2025-10-02 03:08","pubTimestamp":1759345697,"startTime":"0","endTime":"0","summary":"The Australian market is navigating a complex landscape marked by high local inflation, an RBA pause, and geopolitical tensions, all contributing to volatility in sectors such as utilities and discretionary spending. In this environment of uncertainty, growth companies with high insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ttt/titomic-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-7","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ttt/titomic-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AV1.AU","BK7508","BK7093","BK7506","EMR.AU","GTI.AU","BK7036","3DP.AU","BK7104","ACR.AU","XJO.AU","BK7095","BK7016","TTT.AU","VSL.AU","BK7158","LM8.AU","XAO.AU","BK7043","BK7096","BK7129","NWF.AU","BK7116","XKO.AU","FND.AU","WZR.AU","EIQ.AU"],"gpt_icon":0},{"id":"2572597302","title":"BUZZ-Australia's Anatara Lifesciences falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2572597302","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572597302?lang=en_us&edition=fundamental","pubTime":"2025-10-01 11:13","pubTimestamp":1759288430,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Anatara Lifesciences falls on discounted placement** Shares of Anatara Lifesciences ANR.AX fall as much as 6.3% to A$0.015, their lowest since September 22** Shares post biggest intraday pct fall since September 19** Gastrointestinal health products maker receives firm commitments for A$1.2 million  placement** Issue price of A$0.012 represents a discount of 25% to stock's last close** Proceeds to be used to fund ANR's current anti-obesity project and due diligence on other opportunities and assets** Stock down 68.1% YTD, including session's moves  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nL6N3VI05C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ANR.AU","BK7508"],"gpt_icon":0},{"id":"2572301534","title":"BRIEF-Bioxyne Ltd's Unit Well Positioned To Capitalise On Easing Regulations On U.S. Cannabis Classification","url":"https://stock-news.laohu8.com/highlight/detail?id=2572301534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572301534?lang=en_us&edition=fundamental","pubTime":"2025-10-01 09:49","pubTimestamp":1759283365,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Ltd's Unit Well Positioned To Capitalise On Easing Regulations On U.S. Cannabis ClassificationOct 1 (Reuters) - Bioxyne Ltd BXN.AX:UNIT WELL POSITIONED TO CAPITALISE ON EASING REGULATION","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VH10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU","BK7508","BK7111"],"gpt_icon":0},{"id":"2572309900","title":"BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2572309900","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572309900?lang=en_us&edition=fundamental","pubTime":"2025-10-01 09:24","pubTimestamp":1759281870,"startTime":"0","endTime":"0","summary":"BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement Oct 1 (Reuters) - Anatara Lifesciences Ltd ANR.AX:RECEIVES FIRM COMMITMENTS FOR A$1.2M PLACEMENT AT A$0.012/SHAREFurther company coverage: ANR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VH10X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","ANR.AU"],"gpt_icon":0},{"id":"2572303248","title":"Bioxyne Ltd - Unit Well Positioned to Capitalise on Easing Regulations on U.S. Cannabis Classification","url":"https://stock-news.laohu8.com/highlight/detail?id=2572303248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572303248?lang=en_us&edition=fundamental","pubTime":"2025-10-01 07:58","pubTimestamp":1759276689,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VH10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"2572930563","title":"Stripe is planning to apply for an OCC federal trust charter to comply with U.S. stablecoin regulatory requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2572930563","media":"Blockbeats","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572930563?lang=en_us&edition=fundamental","pubTime":"2025-10-01 07:58","pubTimestamp":1759276680,"startTime":"0","endTime":"0","summary":"BlockBeats News, October 1st, according to The Information, Stripe is planning to apply for a national trust charter with federal banking regulators to comply with the upcoming US stablecoin legislation requirements in order to continue issuing stablecoins to its customers. The company is preparing to submit an application to the Office of the Comptroller of the Currency .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/314636","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/314636","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["OCC","LU1668664300.SGD","LU2360107671.USD","LU1861220207.SGD","BK4020","LU0106831901.USD","BK7067","LU1861217088.USD","LU1791807156.HKD","BK4023","BK7508","OCC.AU"],"gpt_icon":0},{"id":"2572330310","title":"Anatara Lifesciences Ltd - Receives Firm Commitments for a$1.2M Placement at a$0.012/Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2572330310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572330310?lang=en_us&edition=fundamental","pubTime":"2025-10-01 07:47","pubTimestamp":1759276020,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VH10X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANR.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2572083133","title":"Timing of CSL's Change of CFO Queried by Bull -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2572083133","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572083133?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:54","pubTimestamp":1759272840,"startTime":"0","endTime":"0","summary":"2250 GMT [Dow Jones]--Citi is slightly puzzled by the timing of pharmaceutical company CSL's CFO change. CSL says Joy Linton will step down as CFO on Oct. 7. She will be succeeded by Chief Strategy Officer Ken Lim and there will be a supporting transition period. \"In our experience, major management change is unusual in the run-up to a big restructuring event like CSL's proposed spin-off of Seqirus, anticipated in 2H of FY 2026,\" analyst Laura Sutcliffe says. Citi assumes that Lim was heavily involved with the decision to spin off the vaccines business. It sees the personnel change as an opportunity for CSL to refresh goals and potentially higher-level strategy over time. Citi has a buy call and A$265.00/share price target on CSL, which ended Tuesday at A$198.20.  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK4023","BK4086","STRK","BK4595","BK4585","SGXZ23171101.USD","LU1169590202.USD","BK4516","LU0728928796.USD","BK4596","LU1169589451.USD","BK7067","CSL.AU","BK7501","SG9999004303.SGD","BK7511","BK4600","BK4588","CSL"],"gpt_icon":1},{"id":"2572370497","title":"BRIEF-Clinuvel Pharmaceuticals Announces Philippe Wolgen Resumes Duties As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2572370497","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572370497?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:34","pubTimestamp":1759271655,"startTime":"0","endTime":"0","summary":"BRIEF-Clinuvel Pharmaceuticals Announces Philippe Wolgen Resumes Duties As CEOOct 1 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:ANNOUNCES PHILIPPE WOLGEN RESUMES DUTIES AS CEOFurther company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VH10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CUV.AU","BK7067"],"gpt_icon":0},{"id":"2572370498","title":"Clinuvel Pharmaceuticals Ltd - Announces DR Philippe Wolgen Resumes Duties as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2572370498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572370498?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:32","pubTimestamp":1759271550,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VH10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","CUV.AU"],"gpt_icon":0},{"id":"2571422233","title":"Immuron Limited Announces Auditor Consent from Grant Thornton in Latest SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2571422233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571422233?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:07","pubTimestamp":1759234068,"startTime":"0","endTime":"0","summary":"Immuron Limited has announced the filing of an auditor's consent from Grant Thornton Audit Pty Ltd, its independent registered accounting firm, as detailed in a recent Form 6-K submitted to the SEC. The consent, dated September 30, 2025, allows for the incorporation of the auditor's report into Immuron's ongoing registration statement on Form F-3. No specific accounting irregularities or issues were disclosed in the filing; the announcement is a standard procedural update related to regulatory compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL2n1g26:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"gpt_icon":0},{"id":"2571345626","title":"Radiopharm Theranostics Ltd: Co Partners With Starpharma on Research and Option Agreement to Develop Novel Radiotherapy Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2571345626","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571345626?lang=en_us&edition=fundamental","pubTime":"2025-09-30 18:12","pubTimestamp":1759227125,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7067","RAD.AU","BK7501","SPL.AU","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":110,"code":"91000000","status":"200"}]}}